{"id":"W4415133357","doi":"10.1007/s13555-025-01543-7","title":"Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata","year":2025,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Clinical trial; Alopecia areata; Phase (matter); Phases of clinical research; MEDLINE","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003263712,0.0001049324,0.0006057856,0.00009464435,0.00005625857,0.000007001021,0.00002954877,0.00013532,0.0000148709],"category_scores_gemma":[0.0002599784,0.0000810618,0.00004920335,0.0000383652,0.0003371918,0.00003301427,0.00001219331,0.00007169595,1.056435e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000001429993,"about_ca_system_score_gemma":0.00009263787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004333089,"about_ca_topic_score_gemma":0.000003892303,"domain_scores_codex":[0.9991279,0.0001057534,0.0004103669,0.0001905131,0.00005298536,0.0001124497],"domain_scores_gemma":[0.9983659,0.001327868,0.00009592999,0.0000948266,0.00004960102,0.00006590167],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8905019,0.002218566,0.01552231,0.000341479,0.0007861626,0.00001952798,0.0006070286,9.12967e-7,0.008658718,0.008648789,0.0007718388,0.07192279],"study_design_scores_gemma":[0.979055,0.002322002,0.002734688,0.000148763,0.0002739319,0.0002696298,0.0001964843,0.004412662,0.001953599,0.004223872,0.004264288,0.0001451074],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.963127,0.007523295,0.02600207,0.001192097,0.00007338117,0.001796774,0.00002519006,0.000007560256,0.0002527025],"genre_scores_gemma":[0.9946183,0.003029065,0.001572091,0.0005685969,0.00003148021,0.00009911482,0.000009671213,0.000006356066,0.00006533527],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08855309,"threshold_uncertainty_score":0.3305604,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0657944768740517,"score_gpt":0.3830563487242735,"score_spread":0.3172618718502218,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}